Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary Tumors

Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary Tumors

(1) <i>Background</i>: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy provide survival benefits to selected patients. We aimed to report our experience and the evolution of our peritoneal surface malignancy program. (2) <i>Methods</i>: From June 2005 to J...

Full description

Bibliographic Details
Main Authors: Philipp Horvath, Can Yurttas, Stefan Beckert, Alfred Königsrainer, Ingmar Königsrainer
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
peritoneal metastases
morbidity
outcome
HIPEC
cytoreductive surgery
Online Access:https://www.mdpi.com/2072-6694/13/10/2471

Similar Items

Similar Items